Geron raises revenue guidance to $230–$240 million
Geron raised revenue guidance to $230—$240 million, citing strong growth. The company also said profitability is in sight, while it expands into deeper community penetration and international markets and advances a pivotal myelofibrosis trial with regulatory engagement.